EnglishУкраїнська
  • Main
  • Useful links
  • Information for Contributors
  • About
  • Editorial board

  • Article
    Stolyarova O.Yu., Solodyannykova O.I., Kmetyuk Ya.V.

    OPPORTUNITIES OF POSITRON-EMMISION TOMOGRAPHY IN RADIATION THERAPY OF LUNG CANCER PATIENTS


    About the author: Stolyarova O.Yu., Solodyannykova O.I., Kmetyuk Ya.V.
    Heading CLINICAL MEDICINE
    Type of article Scentific article
    Annotation In the group of patients with lung cancer, the possibilities of PET / CT-18F-FDG were studied to optimize the planning of radiation therapy. A comparative analysis of the advantages of metabolic image application to determine the size of radiation targets was carried out in order to focus the maximum radiation energy in the most functionally active tumor areas and to reduce side effects on healthy lung tissues. PET / KT-18F-FDG permits to optimize the planning of radiation process specifying the size of the irradiated target. The index of the tumor clinical volume, determined using PET-18F-FDG, is greater, and the value of the macroscopic volume intramodal variable is smaller compared to CT data. Analysis of the metabolic image permits predicting the nature of further radiation, bringing the radiation energy to the most functionally active part of the tumor, reducing the effect on healthy lung tissue, and as a result, reducing the incidence of radiation side effects and improving the quality of life in patients.
    Tags PET / CT-18F-FDG, radiation therapy, lung cancer, radiation therapy planning
    Bibliography
    • Ashley Cox R, Akhurst T, Bressel M, MacManus M, Ball D. Survival and central photopenia detected by fluorine-18 fluoro-deoxy-glucose positron emission tomography (FDG-PET) in patients with locoregional non-small cell lung cancer treated with radiotherapy. Radiother Oncol. 2017. Vol. 26, N6. P.122-137.
    • De Ruysscher D, Faivre-Finn C, Moeller D, Nestle U, Hurkmans CW, Le Péchoux C, Belderbos J, Guckenberger M, Senan S. European Organization for Research and Treatment of Cancer (EORTC) recommendations for planning and delivery of high-dose, high precision radiotherapy for lung cancer. Radiother Oncol. 2017; 27(6): 117-122.
    • Erak MD, Mitrić M, Djuran B, Tesanović D, Vasiljev S. PET/CT fusion in radiotherapy planning for lung cancer – Case reports. Vojnosanit Pregl. 2016; 73(6): 599-602.
    • Everitt S, Callahan J, Obeid E, Hicks RJ, Mac Manus M, Ball D. Acute radiation oesophagitis associated with 2-deoxy-2-[18F]fluoro-d-glucose uptake on positron emission tomography/CT during chemo-radiation therapy in patients with non-small-cell lung cancer. J Med Imaging Radiat Oncol. 2017; 13(6): 202-209.
    • Flechsig P, Frank P, Kratochwil C, Antoch G, Rath D, Moltz J, Rieser M, Warth A, Kauczor HU, Schwartz LH, Haberkorn U, Giesel FL. Radiomic analysis using density threshold for FDG-PET/CT-Based N-Staging in lung cancer patients. Mol Imaging Biol. 2017; 19(2): 315-322.
    • Lee JW, Na JO, Kang DY, Lee SY, Lee SM. Prognostic significance of FDG uptake of bone marrow on PET/CT in patients with non-small-cell lung cancer after curative surgical resection. Clin Lung Cancer. 2017; 18(2): 198-206.
    • Mallorie A, Goldring J, Patel A, Lim E, Wagner T. Assessment of nodal involvement in non-small-cell lung cancer with 18F-FDG-PET/CT: mediastinal blood pool cut-off has the highest sensitivity and tumour SUVmax/2 has the highest specificity. Nucl Med Commun. 2017; 27(6): 182-189.
    • Miljić D, Manojlović-Gačić E, Skender-Gazibara M, Milojević T, Bogosavljević V, Kozarević N, Petrović N, Stojanović M, Pekić S, Doknić M, Petakov M, Popović V. All that glitters on PET is not cancer! 18F-deoxy-glucose avidity versus tumor biology: pituitary incidentaloma in a survivor of two previous unrelated malignancies. Endokrynol Pol. 2017; 68(3): 352-359.
    • Oliver JA, Budzevich M, Hunt D, Moros EG, Latifi K, Dilling TJ, Feygelman V, Zhang G. Sensitivity of image features to noise in conventional and respiratory-gated PET/CT images of lung cancer: uncorrelated noise effects. Technol Cancer Res Treat. 2016; 8(8): 163-169.
    • Riegler G, Karanikas G, Rausch I, Hirtl A, El-Rabadi K, Marik W, Pivec C, Weber M, Prosch H, Mayerhoefer M. Influence of PET reconstruction technique and matrix size on qualitative and quantitative assessment of lung lesions on [18F]-FDG-PET: A prospective study in 37 cancer patients. Eur J Radiol. 2017; 90(5): 20-26.
    • Roy S, Pathy S, Kumar R, Mohanti BK, Raina V, Jaiswal A, Taywade S, Garg K, Thulkar S, Mohan A, Mathur S, Behera D. Efficacy of 18F-fluorodeoxyglucose positron emission tomography/computed tomography as a predictor of response in locally advanced non-small-cell carcinoma of the lung. Nucl Med Commun. 2016; 37(2): 129-138.
    Publication of the article «World of Medicine and Biology» №4(70), 2019 year, 163-167 pages, index UDK 616.24-006:615.849.2
    DOI 10.26724/2079-8334-2019-4-70-163-167